Pharmacokinetic–Pharmacodynamic Modeling of Severity Levels of Extrapyramidal Side Effects With Markov Elements

A major problem in the treatment of schizophrenic patients with current antipsychotic drugs, mainly acting as dopamine-2 receptor antagonists, is the occurrence of side effects such as extrapyramidal symptoms (EPS). Meta-analyses of summary data of EPS occurrence, and receptor occupancies inferred f...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pilla Reddy, V, Petersson, K J, Suleiman, A A, Vermeulen, A, Proost, J H, Friberg, L E
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2012
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3603470/
https://ncbi.nlm.nih.gov/pubmed/23835881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/psp.2012.9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares